查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球给药装置市场（2024-2028）
市场调查报告书
商品编码
1601996

全球给药装置市场（2024-2028）

Global Drug Delivery Devices Market 2024-2028
出版日期: | 出版商: TechNavio | 英文 167 Pages | 订单完成后即时交付

价格

给药装置市场（2024-2028）

2023-2028年，给药设备市场预计将扩大851亿美元，预测期内复合年增长率为6.2%。该报告包括对给药装置市场的总体分析、市场规模和预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。

该报告提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。慢性病盛行率的上升、策略部署的增加以及药物输送设备监管核准的增加正在推动市场发展。

市场范围
基准年 2024年
结束年份 2028年
预测期 2024-2028
成长动力 加速度
与前一年同期比较（2024 年） 5.8%
复合年增长率 6.2%
增量 851亿美元

该报告指出，自动注射器的日益普及是未来几年推动给药设备市场成长的关键因素之一。此外，越来越多地采用先进的药物输送系统以及针对 COVID-19 的新药物和疫苗的开发将带来强劲的市场需求。

目录

第一章执行摘要

  • 市场概况

第二章 Technavio 分析

  • 价格敏感度、生命週期、顾客购买篮子、采用率和购买标准分析
  • 输入和差异化因素的重要性
  • 令人困惑的因素
  • 驱动因素和挑战的影响

第三章 市场状况

  • 市场生态系统
  • 市场特征
  • 价值链分析

第四章 市场规模

  • 市场定义
  • 细分市场分析
  • 市场规模（2023年）
  • 市场展望（2023-2028）

第五章 市场规模表现

  • 全球给药装置市场（2018-2022）
  • 依给药途径分析（2018-2022）
  • 区域分析（2018-2022）
  • 国家分析（2018-2022）

第6章五力分析

  • 五力摘要
  • 买方议价能力
  • 供应商的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争威胁
  • 市场状况

第七章 市场区隔：依管理途径

  • 细分市场
  • 比较：依给药途径
  • 口头：市场规模及预测（2023-2028）
  • 注射：市场规模与预测（2023-2028）
  • 肺：市场规模与预测（2023-2028）
  • 其他：市场规模及预测（2023-2028）
  • 市场机会：依给药途径

第八章 客户状况

  • 客户状况概览

第九章 地区情势

  • 区域细分
  • 区域比较
  • 北美：市场规模与预测（2023-2028）
  • 欧洲：市场规模与预测（2023-2028）
  • 亚洲：市场规模与预测（2023-2028）
  • 世界其他地区：市场规模与预测（2023-2028）
  • 美国：市场规模与预测（2023-2028）
  • 加拿大：市场规模与预测（2023-2028）
  • 德国：市场规模与预测（2023-2028）
  • 中国：市场规模及预测（2023-2028）
  • 英国：市场规模与预测（2023-2028）
  • 日本：市场规模与预测（2023-2028）
  • 西班牙：市场规模与预测（2023-2028）
  • 印度：市场规模与预测（2023-2028）
  • 巴西：市场规模与预测（2023-2028）
  • 沙乌地阿拉伯：市场规模与预测（2023-2028）
  • 市场机会：按地区

第十章 促进因素、挑战、机会、限制因素

  • 市场驱动因素
  • 市场挑战
  • 驱动因素和挑战的影响
  • 市场机会与限制

第十一章竞争格局

  • 概述
  • 竞争格局
  • 混乱的情况
  • 产业风险

第十二章 竞争分析

  • 公司简介
  • 公司排名指数
  • 公司市场定位
  • AbbVie Inc.
  • Antares Pharma Inc.
  • Becton Dickinson and Co.
  • Biocorp
  • F. Hoffmann La Roche Ltd.
  • Johnson and Johnson Inc.
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

第十三章附录

Product Code: IRTNTR72348

Drug Delivery Devices Market 2024-2028

The drug delivery devices market is forecasted to grow by USD 85.1 bn during 2023-2028, accelerating at a CAGR of 6.2% during the forecast period. The report on the drug delivery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic conditions, increased strategic developments, and increase in regulatory approvals for drug delivery devices.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20245.8%
CAGR6.2%
Incremental Value$85.1 bn

Technavio's drug delivery devices market is segmented as below:

By Route Of Administration

    • Oral
    • Injectable
    • Pulmonary
    • Others

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the rising adoption of self-injectable devices as one of the prime reasons driving the drug delivery devices market growth during the next few years. Also, growing adoption of advanced drug delivery systems and development of new drugs and vaccines for covid-19 will lead to sizable demand in the market.

The report on the drug delivery devices market covers the following areas:

    • Drug Delivery Devices Market sizing
    • Drug Delivery Devices Market forecast
    • Drug Delivery Devices Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drug delivery devices market vendors that include 3M Co., AbbVie Inc., Antares Pharma Inc., AptarGroup Inc., Becton Dickinson and Co., Biocorp, Elcam Medical Group, F. Hoffmann La Roche Ltd., Insulet Corp., Johnson and Johnson Inc., Koch Industries Inc., Merck KGaA, Nemera Group, Novartis AG, Pfizer Inc., SHL Medical AG, Teva Pharmaceutical Industries Ltd., uniQure NV, and West Pharmaceutical Services Inc.. Also, the drug delivery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Route of Administration
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value Chain Analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2023
  • 4.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Global - Market size and forecast 2023-2028 ($ billion)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

  • 5.1 Global Drug Delivery Devices Market 2018 - 2022
    • Historic Market Size - Data Table on Global Drug Delivery Devices Market 2018 - 2022 ($ billion)
  • 5.2 Route of Administration segment analysis 2018 - 2022
    • Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
  • 5.3 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • 5.4 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ billion)

6 Five Forces Analysis

  • 6.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 6.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 6.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 6.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 6.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 6.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 6.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

7 Market Segmentation by Route of Administration

  • 7.1 Market segments
    • Chart on Route of Administration - Market share 2023-2028 (%)
    • Data Table on Route of Administration - Market share 2023-2028 (%)
  • 7.2 Comparison by Route of Administration
    • Chart on Comparison by Route of Administration
    • Data Table on Comparison by Route of Administration
  • 7.3 Oral - Market size and forecast 2023-2028
    • Chart on Oral - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
    • Chart on Oral - Year-over-year growth 2023-2028 (%)
    • Data Table on Oral - Year-over-year growth 2023-2028 (%)
  • 7.4 Injectable - Market size and forecast 2023-2028
    • Chart on Injectable - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Injectable - Market size and forecast 2023-2028 ($ billion)
    • Chart on Injectable - Year-over-year growth 2023-2028 (%)
    • Data Table on Injectable - Year-over-year growth 2023-2028 (%)
  • 7.5 Pulmonary - Market size and forecast 2023-2028
    • Chart on Pulmonary - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Pulmonary - Market size and forecast 2023-2028 ($ billion)
    • Chart on Pulmonary - Year-over-year growth 2023-2028 (%)
    • Data Table on Pulmonary - Year-over-year growth 2023-2028 (%)
  • 7.6 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Others - Market size and forecast 2023-2028 ($ billion)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 7.7 Market opportunity by Route of Administration
    • Market opportunity by Route of Administration ($ billion)
    • Data Table on Market opportunity by Route of Administration ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ billion)
    • Data Table on North America - Market size and forecast 2023-2028 ($ billion)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ billion)
    • Data Table on US - Market size and forecast 2023-2028 ($ billion)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.9 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 9.10 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ billion)
    • Data Table on China - Market size and forecast 2023-2028 ($ billion)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.11 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ billion)
    • Data Table on UK - Market size and forecast 2023-2028 ($ billion)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.12 Japan - Market size and forecast 2023-2028
    • Chart on Japan - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
    • Chart on Japan - Year-over-year growth 2023-2028 (%)
    • Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • 9.13 Spain - Market size and forecast 2023-2028
    • Chart on Spain - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Spain - Market size and forecast 2023-2028 ($ billion)
    • Chart on Spain - Year-over-year growth 2023-2028 (%)
    • Data Table on Spain - Year-over-year growth 2023-2028 (%)
  • 9.14 India - Market size and forecast 2023-2028
    • Chart on India - Market size and forecast 2023-2028 ($ billion)
    • Data Table on India - Market size and forecast 2023-2028 ($ billion)
    • Chart on India - Year-over-year growth 2023-2028 (%)
    • Data Table on India - Year-over-year growth 2023-2028 (%)
  • 9.15 Brazil - Market size and forecast 2023-2028
    • Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
    • Chart on Brazil - Year-over-year growth 2023-2028 (%)
    • Data Table on Brazil - Year-over-year growth 2023-2028 (%)
  • 9.16 Saudi Arabia - Market size and forecast 2023-2028
    • Chart on Saudi Arabia - Market size and forecast 2023-2028 ($ billion)
    • Data Table on Saudi Arabia - Market size and forecast 2023-2028 ($ billion)
    • Chart on Saudi Arabia - Year-over-year growth 2023-2028 (%)
    • Data Table on Saudi Arabia - Year-over-year growth 2023-2028 (%)
  • 9.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ billion)
    • Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Company ranking index
    • Company ranking index
  • 12.3 Market positioning of companies
    • Matrix on companies position and classification
    • 3M Co.
    • 3M Co. - Overview
    • 3M Co. - Business segments
    • 3M Co. - Key news
    • 3M Co. - Key offerings
    • 3M Co. - Segment focus
    • SWOT
  • 12.5 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 12.6 Antares Pharma Inc.
    • Antares Pharma Inc. - Overview
    • Antares Pharma Inc. - Product / Service
    • Antares Pharma Inc. - Key offerings
    • SWOT
  • 12.7 Becton Dickinson and Co.
    • Becton Dickinson and Co. - Overview
    • Becton Dickinson and Co. - Business segments
    • Becton Dickinson and Co. - Key news
    • Becton Dickinson and Co. - Key offerings
    • Becton Dickinson and Co. - Segment focus
    • SWOT
  • 12.8 Biocorp
    • Biocorp - Overview
    • Biocorp - Product / Service
    • Biocorp - Key offerings
    • SWOT
  • 12.9 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 12.10 Johnson and Johnson Inc.
    • Johnson and Johnson Inc. - Overview
    • Johnson and Johnson Inc. - Business segments
    • Johnson and Johnson Inc. - Key news
    • Johnson and Johnson Inc. - Key offerings
    • Johnson and Johnson Inc. - Segment focus
    • SWOT
  • 12.11 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 12.12 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 12.13 Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd. - Overview
    • Teva Pharmaceutical Industries Ltd. - Business segments
    • Teva Pharmaceutical Industries Ltd. - Key news
    • Teva Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd. - Segment focus
    • SWOT

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Company Market Positioning
  • Exhibits9: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits10: Overview on criticality of inputs and factors of differentiation
  • Exhibits11: Overview on factors of disruption
  • Exhibits12: Impact of drivers and challenges in 2023 and 2028
  • Exhibits13: Parent Market
  • Exhibits14: Data Table on - Parent Market
  • Exhibits15: Market characteristics analysis
  • Exhibits16: Value Chain Analysis
  • Exhibits17: Offerings of companies included in the market definition
  • Exhibits18: Market segments
  • Exhibits19: Chart on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits20: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  • Exhibits21: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits22: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits23: Historic Market Size - Data Table on Global Drug Delivery Devices Market 2018 - 2022 ($ billion)
  • Exhibits24: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
  • Exhibits25: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
  • Exhibits26: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
  • Exhibits27: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits28: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits29: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits31: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits32: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits33: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits34: Chart on Route of Administration - Market share 2023-2028 (%)
  • Exhibits35: Data Table on Route of Administration - Market share 2023-2028 (%)
  • Exhibits36: Chart on Comparison by Route of Administration
  • Exhibits37: Data Table on Comparison by Route of Administration
  • Exhibits38: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
  • Exhibits39: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
  • Exhibits40: Chart on Oral - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Oral - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Injectable - Market size and forecast 2023-2028 ($ billion)
  • Exhibits43: Data Table on Injectable - Market size and forecast 2023-2028 ($ billion)
  • Exhibits44: Chart on Injectable - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Chart on Pulmonary - Market size and forecast 2023-2028 ($ billion)
  • Exhibits47: Data Table on Pulmonary - Market size and forecast 2023-2028 ($ billion)
  • Exhibits48: Chart on Pulmonary - Year-over-year growth 2023-2028 (%)
  • Exhibits49: Data Table on Pulmonary - Year-over-year growth 2023-2028 (%)
  • Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
  • Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits54: Market opportunity by Route of Administration ($ billion)
  • Exhibits55: Data Table on Market opportunity by Route of Administration ($ billion)
  • Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits57: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits58: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits59: Chart on Geographic comparison
  • Exhibits60: Data Table on Geographic comparison
  • Exhibits61: Chart on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits62: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  • Exhibits63: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits66: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  • Exhibits67: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits68: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits70: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits71: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits72: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  • Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Chart on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits78: Data Table on US - Market size and forecast 2023-2028 ($ billion)
  • Exhibits79: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits82: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
  • Exhibits83: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  • Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits90: Data Table on China - Market size and forecast 2023-2028 ($ billion)
  • Exhibits91: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  • Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibits98: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
  • Exhibits99: Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on Japan - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on Spain - Market size and forecast 2023-2028 ($ billion)
  • Exhibits102: Data Table on Spain - Market size and forecast 2023-2028 ($ billion)
  • Exhibits103: Chart on Spain - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on Spain - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Chart on India - Market size and forecast 2023-2028 ($ billion)
  • Exhibits106: Data Table on India - Market size and forecast 2023-2028 ($ billion)
  • Exhibits107: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibits108: Data Table on India - Year-over-year growth 2023-2028 (%)
  • Exhibits109: Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
  • Exhibits110: Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
  • Exhibits111: Chart on Brazil - Year-over-year growth 2023-2028 (%)
  • Exhibits112: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
  • Exhibits113: Chart on Saudi Arabia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits114: Data Table on Saudi Arabia - Market size and forecast 2023-2028 ($ billion)
  • Exhibits115: Chart on Saudi Arabia - Year-over-year growth 2023-2028 (%)
  • Exhibits116: Data Table on Saudi Arabia - Year-over-year growth 2023-2028 (%)
  • Exhibits117: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits118: Data Tables on Market opportunity By Geographical Landscape ($ billion)
  • Exhibits119: Impact of drivers and challenges in 2023 and 2028
  • Exhibits120: Overview on criticality of inputs and factors of differentiation
  • Exhibits121: Overview on factors of disruption
  • Exhibits122: Impact of key risks on business
  • Exhibits123: Companies covered
  • Exhibits124: Company ranking index
  • Exhibits125: Matrix on companies position and classification
  • Exhibits126: 3M Co. - Overview
  • Exhibits127: 3M Co. - Business segments
  • Exhibits128: 3M Co. - Key news
  • Exhibits129: 3M Co. - Key offerings
  • Exhibits130: 3M Co. - Segment focus
  • Exhibits131: SWOT
  • Exhibits132: AbbVie Inc. - Overview
  • Exhibits133: AbbVie Inc. - Product / Service
  • Exhibits134: AbbVie Inc. - Key news
  • Exhibits135: AbbVie Inc. - Key offerings
  • Exhibits136: SWOT
  • Exhibits137: Antares Pharma Inc. - Overview
  • Exhibits138: Antares Pharma Inc. - Product / Service
  • Exhibits139: Antares Pharma Inc. - Key offerings
  • Exhibits140: SWOT
  • Exhibits141: Becton Dickinson and Co. - Overview
  • Exhibits142: Becton Dickinson and Co. - Business segments
  • Exhibits143: Becton Dickinson and Co. - Key news
  • Exhibits144: Becton Dickinson and Co. - Key offerings
  • Exhibits145: Becton Dickinson and Co. - Segment focus
  • Exhibits146: SWOT
  • Exhibits147: Biocorp - Overview
  • Exhibits148: Biocorp - Product / Service
  • Exhibits149: Biocorp - Key offerings
  • Exhibits150: SWOT
  • Exhibits151: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits152: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits153: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits154: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits155: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits156: SWOT
  • Exhibits157: Johnson and Johnson Inc. - Overview
  • Exhibits158: Johnson and Johnson Inc. - Business segments
  • Exhibits159: Johnson and Johnson Inc. - Key news
  • Exhibits160: Johnson and Johnson Inc. - Key offerings
  • Exhibits161: Johnson and Johnson Inc. - Segment focus
  • Exhibits162: SWOT
  • Exhibits163: Novartis AG - Overview
  • Exhibits164: Novartis AG - Business segments
  • Exhibits165: Novartis AG - Key news
  • Exhibits166: Novartis AG - Key offerings
  • Exhibits167: Novartis AG - Segment focus
  • Exhibits168: SWOT
  • Exhibits169: Pfizer Inc. - Overview
  • Exhibits170: Pfizer Inc. - Product / Service
  • Exhibits171: Pfizer Inc. - Key news
  • Exhibits172: Pfizer Inc. - Key offerings
  • Exhibits173: SWOT
  • Exhibits174: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits175: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits176: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits177: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits178: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits179: SWOT
  • Exhibits180: Inclusions checklist
  • Exhibits181: Exclusions checklist
  • Exhibits182: Currency conversion rates for US$
  • Exhibits183: Research methodology
  • Exhibits184: Information sources
  • Exhibits185: Data validation
  • Exhibits186: Validation techniques employed for market sizing
  • Exhibits187: Data synthesis
  • Exhibits188: 360 degree market analysis
  • Exhibits189: List of abbreviations